IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Daiichi Buys 52.5% Stake in Ranbaxy

11:18 AM MST | November 10, 2008 | Chemical Week Editorial Staff

Daiichi Sankyo (Tokyo) says it has completed the acquisition of a majority stake, or 52.5%, of Ranbaxy Laboratories (Gurgaon, India). Ranbaxy will continue to operate as an autonomous company and will closely work with Daiichi to explore growth opportunities, Daiichi says. Daiichi signed a deal with Ranbaxy last June to acquire shares from Ranbaxy’s founders, the Singh family, and to buy shares through an open offer from ordinary shareholders (CW, June 9/16, p. 33). “The substantial cash being infused by Daiichi Sankyo at this stage will be used to...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa